Loading clinical trials...
Loading clinical trials...
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 or Placebo Treatment in Protocol BA058-05-003
Conditions
Interventions
Alendronate
Locations
25
United States
Lakewood, Colorado, United States
Hialeah, Florida, United States
Bethesda, Maryland, United States
Buenos Aires, Argentina
Brasília, Brazil
Curitiba, Brazil
Start Date
November 20, 2012
Primary Completion Date
October 3, 2016
Completion Date
October 3, 2016
Last Updated
December 11, 2020
NCT06767150
NCT05902078
NCT05010590
NCT02822378
NCT07329543
NCT06079476
Lead Sponsor
Radius Health, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions